ArticleJACC. CardioOncology2021

Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?

Ian C Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.